Evidence map›Paper›PMID 30887099›Full record

ArticleCellular and molecular life sciences : CMLS2019

LION: a simple and rapid method to achieve CRISPR gene editing.

Xi Xiang, Lidan Luo, Michał Nodzyński, Conghui Li, Peng Han, Hongwei Dou, Trine Skov Petersen, Xue Liang, Xiaoguang Pan, Kunli Qu and 9 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Xi XiangBGI Education Center, University of Chinese Academy of Sciences, Shenzhen, 518083, China.
Lidan LuoDepartment of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518033, China.
Michał NodzyńskiDepartment of General Biochemistry, Jagiellonian University, ul. Gronostajowa 7, 30-387, Kraków, Poland.
Conghui LiBGI Education Center, University of Chinese Academy of Sciences, Shenzhen, 518083, China.
Peng HanLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Hongwei DouLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Trine Skov PetersenDepartment of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.
Xue LiangLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Xiaoguang PanLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Kunli QuLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Ling YangLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Yonghui DangLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Xin LiuLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Lars BolundLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Xiuqing ZhangBGI Education Center, University of Chinese Academy of Sciences, Shenzhen, 518083, China.
Guangdong TongDepartment of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518033, China.
Yufeng XingDepartment of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518033, China. yufeng000729@163.com.
Yonglun LuoLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China. alun@biomed.au.dk.ORCID http://orcid.org/0000-0002-0007-7759
Lin LinLars Bolund Institute of Regenerative Medicine, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China. lin.lin@biomed.au.dk.
BGI Group (China) · CNShenzhen Pingle Orthopedic Hospital · CNAarhus University · DKJagiellonian University · PLUniversity of Chinese Academy of Sciences · CNXi'an Jiaotong University · CN

Funding

Lundbeckfonden (DK) R219-2016-1375Sanming Project of Medicine in Shenzhen SZSM201612074Sundhedsvidenskabelige Fakultet, Aarhus Universitet AU-iCRISPRTeknologi og Produktion, Det Frie Forskningsråd 8048-00072ATeknologi og Produktion, Det Frie Forskningsråd DFF-1335-00763ATeknologi og Produktion, Det Frie Forskningsråd DFF-1337-00128
6 · The paper itself

Abstract

The RNA-guided CRISPR-Cas9 technology has paved the way for rapid and cost-effective gene editing. However, there is still a great need for effective methods for rapid generation and validation of CRISPR/Cas9 gRNAs. Previously, we have demonstrated that highly efficient generation of multiplexed CRISPR guide RNA (gRNA) expression array can be achieved with Golden Gate Assembly (GGA). Here, we present an optimized and rapid method for generation and validation in less than 1 day of CRISPR gene targeting vectors. The method (LION) is based on ligation of double-stranded gRNA oligos into CRISPR vectors with GGA followed by nucleic acid purification. Using a dual-fluorescent reporter vector (C-Check), T7E1 assay, TIDE assay and a traffic light reporter assay, we proved that the LION-based generation of CRISPR vectors are functionally active, and equivalent to CRISPR plasmids generated by traditional methods. We also tested the activity of LION CRISPR vectors in different human cell types. The LION method presented here advances the rapid functional validation and application of CRISPR system for gene editing and simplified the CRISPR gene-editing procedures.

Indexed as

CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsBreastCells, CulturedFemaleGene EditingGene TargetingGenetic VectorsHEK293 CellsHumansOvarian NeoplasmsUterine Cervical NeoplasmsRNA, Guide, CRISPR-Cas SystemsCas9CRISPRCRISPR deliveryCRISPR efficiencyGolden Gate Assembly

Identifiers

PMID30887099
PMCPMC11105434
OpenAlexW2921720530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.